Helicobacter pylori and its association with gastric cancer

幽门螺杆菌及其与胃癌的关系

基本信息

  • 批准号:
    09670502
  • 负责人:
  • 金额:
    $ 1.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

Macrophage migration inhibitory factor (MIF) is the first discovered lymphokine. it was originally identified by its ability to prevent the migration of macrophages out of capillary tubes. Since then, the expression of MIF activities has been found at a variety of inflammatory loci, suggesting its role in regulating the function of macrophages in host defence. More recent reports showed that MIF may have functions besides in the immune system. For instance, MIF mRNA and protein are expressed in anterior pituitary cells, brain, embryonic eye lens and differentiating epidermal cells, suggesting its pivotal role in the regulation of neuroendocrine system, cell growth and differentiation. Furthermore, it is possible that MIF has a role in the gastric mucosal inflammation caused by Helicobacter pylon (HP) infection and the development of gastric cancer in an inflamed gatric mcosa The aim of this study was to elucidatee the role of MIF in the patliogenesis of gastric diseases associated with … More HP infectionFirst, we examined the distribution of MIF in the gastrointestinal tract. MIF mRNA and protein were strongly expressed in the rat gastric mucoca and to a lesser extent in the oesophagus, small intestine and colon by Northern blot analysis and immunoblotting. By immunohistochemical study, positive MIF staining was confined within the cytoplasm of parietal cells. Chief cells and surface mucous cells were negative for MIF staining. Intraperitoneal injection of rat gastrin I caused a decline of MIF mRNA level. After 6 hours of injection, the level of MIF mRNA returned to the level before injection. These results suggest that MIF may play an important role in parietal cell physiology. In human gastric mucosa infected with HP, MIF was strongly expressed in infiltrating lymphocytes as well as gastric parietal cells. Finally, we examined the bood level of MIF before and after the eradication therapy for HP infection. We found that the serum MIF concentration in patients with HP infection was lower than that of HP negative control subjects, and after successful eradication therapy, MIF concentration raised to the level comparable to that of control subjects. These results suggest that the local inflammatory response to HP may have the profound influence on the immune system. Less
巨噬细胞迁移抑制因子(MIF)是第一个发现的淋巴因子。它最初是通过防止巨噬细胞从毛细管中迁移的能力来确定的。从那时起,在多种炎症基因座上发现了MIF活性的表达,这表明其在确定巨噬细胞在宿主防御中的功能中的作用。最近的报告显示,除了免疫系统外,MIF可能具有功能。例如,MIF mRNA和蛋白质在前垂体细胞,脑,胚胎眼镜和分化表皮细胞中表达,这表明其在调节神经内分泌系统,细胞生长和分化中的关键作用。 Furthermore, it is possible that MIF has a role in the gastric mucosal injection caused by Helicobacter pylon (HP) infection and the development of gastric cancer in an inflamed gatric mcosa The aim of this study was to elucidatee the role of MIF in the Patliogenesis of gastric diseases associated with … More HP infectionFirst, we examined the distribution of MIF in the gastrointestinal tract.通过北印迹分析和免疫印迹,在大鼠胃粘膜中强烈表达了MIF mRNA和蛋白质,在大鼠胃粘膜中强烈表达,小肠和结肠。通过免疫组织化学研究,将阳性MIF染色限制在顶叶细胞的细胞质内。主要细胞和表面粘液细胞为MIF染色阴性。腹膜内注射大鼠胃蛋白I导致MIF mRNA水平下降。注射6小时后,MIF mRNA的水平在注射前恢复了水平。这些结果表明,MIF可能在顶叶细胞生理中起重要作用。在感染HP的人胃粘膜中,MIF在浸润淋巴细胞和胃顶细胞中强烈表达。最后,我们检查了HP感染放射治疗前后MIF的船水平。我们发现,HP感染患者的血清MIF浓度低于HP阴性对照组受试者的血清MIF浓度,在成功放射治疗后,MIF浓度升高到与对照组相当的水平。这些结果表明,对HP的局部炎症反应可能对免疫系统产生深远的影响。较少的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M.Asaka, H.Takeda, et al.: "What role does Helicobacter pylori play in gastric cancer?" Gastroenterology. 113 (Suppl.). S56-60 (1997)
M.Asaka、H.Takeda 等人:“幽门螺杆菌在胃癌中发挥什么作用?”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
武田宏司: "H.pylori感染症と酸分泌および消化管ホルモンの動態" 消化器科. 24. 255-262 (1997)
Hiroshi Takeda:“幽门螺杆菌感染、胃酸分泌和胃肠道激素动态”《胃肠病学》24. 255-262 (1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
武田宏司: "Helicobacter pylori除菌療法における酸分泌抑制の意義" Helicobacter Research. 3. 266-273 (1997)
Hiroshi Takeda:“胃酸分泌抑制在幽门螺杆菌根除治疗中的意义”Helicobacter Research 3. 266-273 (1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
西平順: "マクロファージ遊走阻止因子(MIF)の新たな機能とその生理的意義" 生化学. 69. 1026-1029 (1997)
Jun Nishihira:“巨噬细胞迁移抑制因子(MIF)的新功能及其生理意义”《生物化学》69。1026-1029(1997)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H Takeda, et al.: "Helicobacter pylori infection and gastrointestinal hormones" Shoukakika. 24 (in Japanese). 255-262 (1997)
H Takeda 等:“幽门螺杆菌感染与胃肠激素”Shoukakika。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKEDA Hiroshi其他文献

TAKEDA Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKEDA Hiroshi', 18)}}的其他基金

Research on interrelationship between management philosophy, investment behavior, and financial policy in amoeba management
阿米巴经营中管理理念、投资行为与财务政策的相互关系研究
  • 批准号:
    19K01866
  • 财政年份:
    2019
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research on amoeba management from corporate finance perspective
公司财务视角下的阿米巴经营研究
  • 批准号:
    15K03610
  • 财政年份:
    2015
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rikkunshito increased hypothalamic SIRT1 activity
Rikkunshito 增加下丘脑 SIRT1 活性
  • 批准号:
    25460922
  • 财政年份:
    2013
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Relationship between the gloval solvability and a non-lineaer action for a nonlinear damped wave equation
非线性阻尼波动方程的全局可解性与非线性作用之间的关系
  • 批准号:
    23740116
  • 财政年份:
    2011
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Elucidation of the epigenetic regulation on the stress resistance
阐明抗逆性的表观遗传调控
  • 批准号:
    22590086
  • 财政年份:
    2010
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The mechanism by which rikkunshito increases acylated ghrelin
rikkunshito 增加酰化 ghrelin 的机制
  • 批准号:
    22590676
  • 财政年份:
    2010
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dynamics and maintenance of soil animal communities depending upon the fine root production in tropical seasonal forests
土壤动物群落的动态和维持取决于热带季节性森林细根的生产
  • 批准号:
    17405029
  • 财政年份:
    2005
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Comparative Study about Effectiveness of the Care Systems : Japan, Sweden UK and Germany
日本、瑞典、英国和德国护理系统有效性的比较研究
  • 批准号:
    10041089
  • 财政年份:
    1998
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
Comparative Study on the Administration and Finance of the Care Security Systems: Japan and European Counties
日本与欧洲国家护理保障制度管理与财务的比较研究
  • 批准号:
    10490028
  • 财政年份:
    1998
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Education for Information Processing with the Multi-Media Computer System and Network System
多媒体计算机系统和网络系统信息处理教育
  • 批准号:
    07680234
  • 财政年份:
    1995
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

SUMO化修饰GHR在H.pylori诱导巨噬细胞极化中的作用及机制研究
  • 批准号:
    82360119
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
基于脲酶结构“敏感点”研究表小檗碱治疗H. pylori不产生耐药的机制
  • 批准号:
    82304837
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于CXCR2/p38/p53/p21衰老通路探讨固本通络方治疗H.pylori感染相关的萎缩性胃炎的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
NFAT1/TCEAL7轴诱导的线粒体功能障碍参与BMP通路介导H.pylori相关胃解痉多肽表型化生的分子机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
H.pylori介导GNB4去甲基化修饰在胃癌发生发展中的作用机制及其作为临床诊断标志物的研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目

相似海外基金

網羅的遺伝子発現解析技術を用いたH.pylori未感染胃癌の発癌機構の解明
利用综合基因表达分析技术阐明未感染H.pylori的胃癌的致癌机制
  • 批准号:
    24K11095
  • 财政年份:
    2024
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting NuoD for the treatment of H. pylori
靶向 NuoD 治疗幽门螺杆菌
  • 批准号:
    10659783
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
H. Pylori Relationship to Digestive Diseases and Cancer
幽门螺杆菌与消化系统疾病和癌症的关系
  • 批准号:
    10846242
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Search of novel H. pylori virulence factors related to gastric cancer development
寻找与胃癌发生相关的新型幽门螺杆菌毒力因子
  • 批准号:
    22H02871
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
人工知能・新型ゲノムデータ駆動型アプローチに基づく革新的胃癌統合医療の創成
基于人工智能和新的基因组数据驱动方法创建创新的胃癌综合医学
  • 批准号:
    22H02975
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了